Skip to content

Effects of early suture removal on surgical incision healing: a single-center, randomized, self-controlled clinical trial

Effects of early suture removal on surgical incision healing

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044789
Enrollment
Unknown
Registered
2021-03-27
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scar

Interventions

Early Group:Suture removal time according to the operation site: head, face and neck 2-3 days
Lower abdomen, perineum 3-5 days
Chest, upper abdomen, back, buttocks 3-5 days
Extremities: 4-6 days.
Control Group:Suture removal time according to the surgical site: 4-5 days for the head, face and neck
Lower abdomen, perineum 6-7 days
Chest, upper abdomen, back, buttocks 7-9 days
Extremities: 10-12 days.

Sponsors

Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years; 2. The incision length is more than (including) 4cm; 3. Skin Fitzpatrick classification III/IV; 4. Perform cutaneous surgery and plan to suture the patient in one stage.

Exclusion criteria

Exclusion criteria: 1. Suspected keloid, or a history of keloid, or a family history of keloid; 2. Patients who need to delay closing the wound; 3. Suffers from serious skin diseases, such as psoriasis, scleroderma, etc.; 4. With clinical manifestations of obvious or unstable systemic disease, based on May cause interference to the results of safety indicators shall be excluded, including malignant tumors, is difficult to control high blood pressure, diabetes, is difficult to control instability and organic pneumonia, kidney or liver disease, unstable myocardial ischemic diseases, expansionary myocardial disease, cardiac conduction disorders or instability of cardiovascular disease, etc..

Design outcomes

Primary

MeasureTime frame
Incidence of wound infection;Incidence of wound dehiscence;

Secondary

MeasureTime frame
Patient and Observer Scar Assessment Scale (POSAS) Score;Scar width;Suture markers;

Countries

China

Contacts

Public ContactGao Zhen

Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

shgaozhen@126.com+86 1356292863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026